124 related articles for article (PubMed ID: 2930836)
1. Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes.
Rambaldi A; Terao M; Bettoni S; Bassan R; Battista R; Barbui T; Garattini E
Blood; 1989 Apr; 73(5):1113-5. PubMed ID: 2930836
[TBL] [Abstract][Full Text] [Related]
2. Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor.
Rambaldi A; Terao M; Bettoni S; Tini ML; Bassan R; Barbui T; Garattini E
Blood; 1990 Dec; 76(12):2565-71. PubMed ID: 1702329
[TBL] [Abstract][Full Text] [Related]
3. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
[TBL] [Abstract][Full Text] [Related]
4. The population of paroxysmal nocturnal hemoglobinuria neutrophils deficient in decay-accelerating factor is also deficient in alkaline phosphatase.
Burroughs SF; Devine DV; Browne G; Kaplan ME
Blood; 1988 Apr; 71(4):1086-9. PubMed ID: 2451546
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil alkaline phosphatase activity in the urinary neutrophils of a patient with chronic myelogenous leukemia.
Janković G; Petrović M; Colović M; Zilić M; Dotlić R
Am J Hematol; 1991 Jan; 36(1):67-8. PubMed ID: 1984687
[TBL] [Abstract][Full Text] [Related]
6. Induction of alkaline phosphatase activity in chronic myeloid leukemia cells: in vitro studies and speculative hypotheses.
De Renzo A; Micera V; Vaglio S; Luciano L; Selleri C; Rotoli B
Am J Hematol; 1990 Dec; 35(4):278-80. PubMed ID: 2239924
[TBL] [Abstract][Full Text] [Related]
7. Induction of neutrophil alkaline phosphatase gene expression by granulocyte colony-stimulating factor in chronic myelogenous leukemia.
Tsushita K; Hotta T; Ichikawa A; Murate T; Saito H
Int J Hematol; 1993 Jan; 57(1):45-52. PubMed ID: 7682859
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil alkaline phosphatase activity in paroxysmal nocturnal hemoglobinuria.
Mori M; Tanaka A; Ikebuchi K; Kurata H; Miwa A; Murai Y
Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):791-8. PubMed ID: 3687328
[No Abstract] [Full Text] [Related]
9. [Periodic acid-Schiff reaction of erythroblasts in erythremic myelosis and neutrophil alkaline phosphatase activity in paroxysmal nocturnal hemoglobinuria].
Horie K
Rinsho Byori; 1969 Jan; 17(1):42-3. PubMed ID: 4181627
[No Abstract] [Full Text] [Related]
10. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients].
Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C
Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136
[TBL] [Abstract][Full Text] [Related]
11. Paroxysmal nocturnal hemoglobinuria: an historical overview.
Parker CJ
Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
[TBL] [Abstract][Full Text] [Related]
12. [Neutrophil alkaline phosphatase score].
Nakamura Y; Waga K; Mitani K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
[No Abstract] [Full Text] [Related]
13. Abnormal LTC4 synthase RNA degradation in neutrophils from CML patients.
Roos C; Sjölinder M; Stenke L; Tornhamre S
Br J Haematol; 2004 Mar; 124(6):739-45. PubMed ID: 15009061
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelogenous leukemia (CML) associated with granulocyte colony-stimulating factor (G-CSF)-producing mesothelioma.
Masuda Y; Kizaki M; Ueno H; Mori S; Takayama N; Muto A; Matsushita H; Ikeda E; Kawai Y; Ikeda Y
Leukemia; 1995 Sep; 9(9):1591-4. PubMed ID: 7544855
[No Abstract] [Full Text] [Related]
15. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.
Ploug M; Eriksen J; Plesner T; Hansen NE; Danø K
Eur J Biochem; 1992 Sep; 208(2):397-404. PubMed ID: 1325906
[TBL] [Abstract][Full Text] [Related]
16. BCR/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia.
Salesse S; Verfaillie CM
Mol Cancer Ther; 2003 Feb; 2(2):173-82. PubMed ID: 12589034
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells.
Gianní M; Terao M; Zanotta S; Barbui T; Rambaldi A; Garattini E
Blood; 1994 Apr; 83(7):1909-21. PubMed ID: 7511442
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of glycosyl phosphatidylinositol-anchored proteins in polymorphonuclear leukocytes from patients with paroxysmal nocturnal hemoglobinuria with low-grade hemolysis.
Shibuya K; Ninomiya H; Muraki Y; Nagasawa T; Abe T
Int J Hematol; 1993 Aug; 58(1-2):15-20. PubMed ID: 7693026
[TBL] [Abstract][Full Text] [Related]
19. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
Farhi DC; Luckey CN; Siddiqui AM
Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
Kawakami Z; Ninomiya H; Tomiyama J; Abe T
Br J Haematol; 1990 Apr; 74(4):508-13. PubMed ID: 1693286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
